参考文献 [1] Munshi A, Kurland JF, Nishikawa T, et al. Inhibition of constitutively activated nuclear factor-kappaB radiosensitizes human melanoma cells. Mol Cancer Ther. 2004 ;3(8):985-92. [2] Ahn KS, Sethi G, Krishnan K, et al. Gamma-tocotrienol inhibits nuclear factor-kappaB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis. J Biol Chem. 2007;5;282(1):809-20. [3] Cheng Qingwen, Lee Ho H, Li Ying, et al. Upregulation of Bcl-x and Bf-1 as a potential mechanism of chemo-resistance, which can be overcome by NF-kB inhibition. Oncogene. 2000;19, 4936~40. [4] Riker AI, Enkemann SA, Fodstad O, et al. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis.BMC Med Genomics. 2008; 28;1:13. [5] Tang L, Su M, Zhang Y, et al. Endothelin-3 is produced by metastatic melanoma cells and promotes melanoma cell survival. J Cutan Med Surg. 2008;12(2):64-70 [6] Spinella F, Rosanò L, Di Castro V, et al.Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.Cancer Res. 2007;67(4):1725-34. [7] Shishodia S, Gutierrez AM, Lotan R, et al. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products. Cancer Res. 2005;65(20):9555-65. [8] Yang J, Amiri KI, Burke JR, et al. BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathways. Clin Cancer Res. 2006;12(3 Pt 1):950-60. [9] Olsson A, Norberg M, Okvist A, et al. Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia. Br J Cancer. 2007;97(6):769-77. [10] Piva R, Pellegrino E, Mattioli M,et al.Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes. J Clin Invest. 2006;116(12):3171-82. [11] Okazawa M, Shiraki T, Ninomiya H, et al. Endothelin-induced apoptosis of A375 human melanoma cells. J Biol Chem. 1998;273(20):12584-92. [12] Lahav R, Suvà ML, Rimoldi D, et al. Endothelin receptor B inhibition triggers apoptosis and enhances angiogenesis in melanomas.Cancer Res. 2004;64(24):8945-53. |